ArticleHarm reduction journal2005
Harm reduction--the cannabis paradox.
Article in Harm reduction journal, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Conceptualizing 'cannabis harm reduction': lessons learned from cannabis compassion clubs and medical dispensaries in British Columbia (Canada).Harm reduction journal · 2025Article
- Facilitators of and obstacles to practitioners' adoption of harm reduction in cannabis use: a scoping review.Harm reduction journal · 2024Article
- Facilitators of and barriers to healthcare providers' adoption of harm reduction in cannabis use: a scoping review protocol.BMJ open · 2024Article
- Illegal drugs and periodontal conditions.Periodontology 2000 · 2022Review
- "Returning to Ordinary Citizenship": A Qualitative Study of Chinese PWUD's Self-Management Strategies and Disengagement Model of Identity.Behavioral sciences (Basel, Switzerland) · 2022Article
- Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use.International journal of environmental research and public health · 2022Article
- Development and validation of an open-source, disposable, 3D-printedERJ open research · 2021Article
- Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)-tetrahydrocannabinol challenge tests.British journal of clinical pharmacology · 2016Article
- 'Tis in our nature: taking the human-cannabis relationship seriously in health science and public policy.Frontiers in psychiatry · 2013Article
- Reader's response to "Endocannabinoids--the brain's own marijuana--may be linked to the metabolic syndrome".MedGenMed : Medscape general medicine · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article examines harm reduction from a novel perspective. Its central thesis is that harm reduction is not only a social concept, but also a biological one. More specifically, evolution does not make moral distinctions in the selection process, but utilizes a cannabis-based approach to harm reduction in order to promote survival of the fittest. Evidence will be provided from peer-reviewed scientific literature that supports the hypothesis that humans, and all animals, make and use internally produced cannabis-like products (endocannabinoids) as part of the evolutionary harm reduction program. More specifically, endocannabinoids homeostatically regulate all body systems (cardiovascular, digestive, endocrine, excretory, immune, nervous, musculo-skeletal, reproductive). Therefore, the health of each individual is dependent on this system working appropriately.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.